Friday, August 01, 2025 7:55:06 PM
Well you've diversified your risk somewhat by recently buying ICU below 60c I recall .
I've just posted about a possible Fresenius buyout ...after approval ...of ICU on that board ...feel free to comment .
Re UNCY
At some pt buyers will emerge .
Say we get a Class 2 resubmission ...once thats out there , some will buy knowing that come mid / late 2026 OLC has a 90% chance of FDA approval .
Some may wait for a Class 2 AND a capital raise ...but others may just figure the capital raise is priced in and buy anyway .
Of course if we are fortunate enough to get a Class 1 re submission ...we will all be moaning about not having a large enough position.
Good luck
Kiwi
I've just posted about a possible Fresenius buyout ...after approval ...of ICU on that board ...feel free to comment .
Re UNCY
At some pt buyers will emerge .
Say we get a Class 2 resubmission ...once thats out there , some will buy knowing that come mid / late 2026 OLC has a 90% chance of FDA approval .
Some may wait for a Class 2 AND a capital raise ...but others may just figure the capital raise is priced in and buy anyway .
Of course if we are fortunate enough to get a Class 1 re submission ...we will all be moaning about not having a large enough position.
Good luck
Kiwi
Recent UNCY News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:30:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:30:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 08:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 11:51:50 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 10:30:46 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/30/2026 11:04:02 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/30/2026 11:02:10 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 11:00:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/06/2026 01:11:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 11:29:20 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 10:32:02 AM
- Unicycive shares gain as FDA accepts resubmitted OLC NDA • IH Market News • 01/29/2026 03:01:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:14 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/14/2025 10:09:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 02:12:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:39:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2025 11:30:13 AM
- UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit • PR Newswire (US) • 10/14/2025 06:55:00 AM
